Senior R&D Quality & Verification Lead at Illumina

Tel Aviv-Yafo, TA, Israel

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, Genomics, TechnologyIndustries

Requirements

Technically strong and hands-on leader
Passionate about building reliable, compliant, and high-performing healthcare-grade SaaS products
Experience leading verification strategy, quality assurance, and release readiness for SaaS platforms (implied from role demands)

Responsibilities

Define and execute the comprehensive verification and validation strategy for Emedgene’s cloud SaaS platform — spanning web UI, APIs, backend microservices, and data pipelines
Ensure performance, scalability, and reliability are embedded into the verification lifecycle to validate large-scale genomic workloads and concurrency under real-world conditions
Own release quality and readiness planning across all release trains
Define entry/exit criteria, manage defect review, prioritization, assignment, and resolution tracking, and provide release readiness reports
Lead risk assessments, pre-release validation, and sign-off activities in alignment with R&D, Product, and Quality leadership
Collaborate with DevOps and Operations on deployment planning, canary releases, rollback strategies, and post-deployment validation
Serve as the technical quality owner for production escalations
Partner with Customer Support and R&D to triage, prioritize, and resolve customer-reported issues efficiently
Conduct root cause analyses and lessons-learned reviews following major incidents or releases
Implement corrective and preventive actions (CAPAs) and improve test coverage and automation to minimize recurrence of production issues
Lead the evolution of the automation framework to increase reliability, coverage, and speed
Ensure automated verification covers functional, performance, and scalability aspects and integrates seamlessly into CI/CD pipelines
Maintain compliance with ISO 13485, IEC 62304, FDA 21 CFR Part 11, IVDR and AI ACT standards
Guarantee full traceability between requirements, verification, and validation results using JAMA or equivalent tools
Define and monitor key quality KPIs (automation coverage, defect leakage, performance benchmarks, release success rate, escalations)

Skills

Key technologies and capabilities for this role

VerificationQuality AssuranceSaaSGenomic AnalysisCloud PlatformAutomationPerformance TestingScalabilityReliabilityDevOpsR&DRelease ManagementLeadership

Questions & Answers

Common questions about this position

What is the work arrangement for this role?

The role is full time and based onsite 4 out of 5 days a week within the Tel Aviv, Israel Office.

What benefits does Illumina offer?

Illumina's employee benefits are industry-leading and include flexible time off, private medical insurance, compassion and care time off, leisure travel insurance, pension, employee stock purchasing program, volunteer time off, and much more.

What are the key responsibilities of this role?

The role involves leading verification and quality strategy for the SaaS platform, owning release quality and readiness planning, and managing escalations to drive continuous improvement.

What is the company culture like at Illumina?

Illumina fosters a culture where every person has the opportunity to make a difference, surrounded by extraordinary people, inspiring leaders, and world-changing projects.

What makes a strong candidate for this position?

A strong candidate is a technically strong, hands-on leader passionate about building reliable, compliant, and high-performing healthcare-grade SaaS products, with experience leading cross-functional teams in R&D, Product, DevOps, and Support.

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free